tradingkey.logo

Neuropace Inc

NPCE
15.670USD
+0.180+1.16%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
521.51MMarktkapitalisierung
VerlustKGV TTM

Neuropace Inc

15.670
+0.180+1.16%

mehr Informationen über Neuropace Inc Unternehmen

NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. The RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorders.

Neuropace Inc Informationen

BörsenkürzelNPCE
Name des UnternehmensNeuropace Inc
IPO-datumApr 22, 2021
CEOBecker (Joel D)
Anzahl der mitarbeiter184
WertpapierartOrdinary Share
GeschäftsjahresendeApr 22
Addresse455 N. Bernardo Avenue
StadtMOUNTAIN VIEW
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl94043
Telefon16502372700
Websitehttps://www.neuropace.com/
BörsenkürzelNPCE
IPO-datumApr 22, 2021
CEOBecker (Joel D)

Führungskräfte von Neuropace Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
593.35K
+1431.00%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
64.90K
-1338.00%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
51.85K
+51850.00%
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
39.16K
+678.00%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
18.01K
+904.00%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
13.95K
+715.00%
Ms. Renee Ryan
Ms. Renee Ryan
Independent Director
Independent Director
--
--
Ms. Lisa Andrade
Ms. Lisa Andrade
Independent Director
Independent Director
--
--
Mr. Joel D. Becker
Mr. Joel D. Becker
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. R. Scott (Scott) Huennekens
Mr. R. Scott (Scott) Huennekens
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
593.35K
+1431.00%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
64.90K
-1338.00%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
51.85K
+51850.00%
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
39.16K
+678.00%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
18.01K
+904.00%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
13.95K
+715.00%

Umsatzaufteilung

FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q1
FY2023
FY2022
FY2021
FY2020
FY2019
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United States
27.35M
0.00%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Mon, Nov 17
Aktualisiert: Mon, Nov 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Accelmed Growth Partners Management Ltd
13.40%
Polar Capital LLP
9.36%
Soleus Capital Management, L.P.
8.94%
OrbiMed Advisors, LLC
7.90%
Morgan Stanley & Co. LLC
7.67%
Andere
52.72%
Aktionäre
Aktionäre
Anteil
Accelmed Growth Partners Management Ltd
13.40%
Polar Capital LLP
9.36%
Soleus Capital Management, L.P.
8.94%
OrbiMed Advisors, LLC
7.90%
Morgan Stanley & Co. LLC
7.67%
Andere
52.72%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
25.91%
Private Equity
21.30%
Hedge Fund
19.29%
Investment Advisor
17.23%
Research Firm
8.41%
Individual Investor
2.72%
Pension Fund
0.29%
Bank and Trust
0.08%
Venture Capital
0.03%
Andere
4.75%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
209
30.65M
92.64%
-6.33M
2025Q3
198
31.14M
94.13%
-2.95M
2025Q2
184
29.13M
88.81%
-1.17M
2025Q1
183
29.76M
92.98%
+2.27M
2024Q4
144
26.53M
86.07%
-49.99K
2024Q3
134
26.01M
86.62%
-1.02M
2024Q2
129
25.88M
90.53%
+502.69K
2024Q1
131
24.82M
87.55%
-513.24K
2023Q4
113
24.06M
92.70%
-1.70M
2023Q3
103
24.86M
97.20%
-1.10M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Accelmed Growth Partners Management Ltd
4.43M
13.4%
--
--
Apr 09, 2025
Polar Capital LLP
3.10M
9.36%
--
--
Sep 30, 2025
Soleus Capital Management, L.P.
2.96M
8.94%
+645.00K
+27.89%
Sep 30, 2025
OrbiMed Advisors, LLC
2.61M
7.9%
--
--
Sep 30, 2025
Morgan Stanley & Co. LLC
2.54M
7.67%
-38.81K
-1.51%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.64M
4.95%
+103.79K
+6.76%
Sep 30, 2025
The Vanguard Group, Inc.
1.44M
4.34%
+66.57K
+4.86%
Sep 30, 2025
First Light Asset Management, LLC
1.36M
4.11%
-20.34K
-1.47%
Sep 30, 2025
Armistice Capital LLC
1.30M
3.92%
+145.66K
+12.64%
Sep 30, 2025
Kent Lake PR LLC
1.00M
3.02%
+75.00K
+8.11%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares Neuroscience and Healthcare ETF
0.64%
Principal U.S. Small-Cap ETF
0.05%
iShares Micro-Cap ETF
0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
ProShares Hedge Replication ETF
0.02%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Mehr Anzeigen
iShares Neuroscience and Healthcare ETF
Anteil0.64%
Principal U.S. Small-Cap ETF
Anteil0.05%
iShares Micro-Cap ETF
Anteil0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0.02%
ProShares Hedge Replication ETF
Anteil0.02%
ProShares UltraPro Russell2000
Anteil0.01%
iShares Russell 2000 ETF
Anteil0.01%
iShares Russell 2000 Growth ETF
Anteil0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Anteil0.01%
Proshares Ultra Russell 2000
Anteil0.01%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI